STSA Annual EBIT
-$70.04 M
-$19.03 M-37.31%
31 December 2022
Summary:
As of February 5, 2025, STSA annual earnings before interest & taxes is -$70.04 million, with the most recent change of -$19.03 million (-37.31%) on December 31, 2022. During the last 3 years, it has fallen by -$42.35 million (-152.92%).STSA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA Quarterly EBIT
-$10.29 M
+$12.84 M+55.50%
31 March 2023
Summary:
As of February 5, 2025, STSA quarterly earnings before interest & taxes is -$10.29 million, with the most recent change of +$12.84 million (+55.50%) on March 31, 2023. Over the past year, it has increased by +$5.21 million (+33.61%).STSA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA TTM EBIT
-$64.83 M
+$5.21 M+7.44%
31 March 2023
Summary:
As of February 5, 2025, STSA TTM earnings before interest & taxes is -$64.83 million, with the most recent change of +$5.21 million (+7.44%) on March 31, 2023. Over the past year, it has dropped by -$8.71 million (-15.53%).STSA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -37.3% | +33.6% | -15.5% |
3 y3 years | -152.9% | +12.0% | -76.6% |
5 y5 years | -1258.2% | -548.6% | -134.1% |
STSA EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | +1260.8% | +548.6% | +3985.1% |
Satsuma Pharmaceuticals EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | -$10.29 M(-55.5%) | -$64.83 M(-7.4%) |
Dec 2022 | -$70.04 M(+37.3%) | -$23.13 M(+52.8%) | -$70.04 M(+12.2%) |
Sept 2022 | - | -$15.14 M(-6.9%) | -$62.44 M(+3.0%) |
June 2022 | - | -$16.27 M(+4.9%) | -$60.60 M(+8.0%) |
Mar 2022 | - | -$15.51 M(-0.1%) | -$56.12 M(+10.0%) |
Dec 2021 | -$51.01 M(+8.0%) | -$15.53 M(+16.8%) | -$51.01 M(+6.4%) |
Sept 2021 | - | -$13.30 M(+12.8%) | -$47.96 M(+2.5%) |
June 2021 | - | -$11.79 M(+13.3%) | -$46.77 M(+1.3%) |
Mar 2021 | - | -$10.40 M(-16.6%) | -$46.16 M(-2.7%) |
Dec 2020 | -$47.21 M | -$12.48 M(+3.0%) | -$47.46 M(+3.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2020 | - | -$12.11 M(+8.4%) | -$45.68 M(+9.5%) |
June 2020 | - | -$11.18 M(-4.5%) | -$41.71 M(+13.6%) |
Mar 2020 | - | -$11.70 M(+9.4%) | -$36.70 M(+32.5%) |
Dec 2019 | -$27.69 M(+281.7%) | -$10.69 M(+31.4%) | -$27.69 M(+43.8%) |
Sept 2019 | - | -$8.14 M(+31.9%) | -$19.26 M(+51.6%) |
June 2019 | - | -$6.17 M(+129.1%) | -$12.71 M(+94.4%) |
Mar 2019 | - | -$2.69 M(+19.4%) | -$6.54 M(+70.1%) |
Dec 2018 | -$7.26 M(+40.7%) | -$2.26 M(+42.2%) | -$3.84 M(+142.2%) |
Sept 2018 | - | -$1.59 M | -$1.59 M |
Dec 2017 | -$5.16 M | - | - |
FAQ
- What is Satsuma Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals annual EBIT year-on-year change?
- What is Satsuma Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals quarterly EBIT year-on-year change?
- What is Satsuma Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals TTM EBIT year-on-year change?
What is Satsuma Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of STSA is -$70.04 M
What is the all time high annual EBIT for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high annual earnings before interest & taxes is -$5.15 M
What is Satsuma Pharmaceuticals annual EBIT year-on-year change?
Over the past year, STSA annual earnings before interest & taxes has changed by -$19.03 M (-37.31%)
What is Satsuma Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of STSA is -$10.29 M
What is the all time high quarterly EBIT for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$1.59 M
What is Satsuma Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, STSA quarterly earnings before interest & taxes has changed by +$5.21 M (+33.61%)
What is Satsuma Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of STSA is -$64.83 M
What is the all time high TTM EBIT for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high TTM earnings before interest & taxes is -$1.59 M
What is Satsuma Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, STSA TTM earnings before interest & taxes has changed by -$8.71 M (-15.53%)